Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
Press Releases
September 14, 2011
Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference in London
...
Read More
September 9, 2011
Emergent BioSolutions Co-Hosts Biopreparedness Conference with the French High Committee for Civil Defense
...
Read More
August 26, 2011
Results of Emergent BioSolutions Phase 1a Study on Adjuvanted BioThrax Anthrax Vaccine Published in the Journal Vaccine
...
Read More
August 17, 2011
Emergent Announces Initiation of a Phase 1b/2 Study of TRU-016 in Combination with Rituximab and Bendamustine in Subjects with Relapsed – Indolent Lymphoma
...
Read More
August 11, 2011
New Tuberculosis Vaccine Enters Phase IIb Proof-of-Concept Trial in People Living with HIV in Senegal and South Africa
...
Read More
August 9, 2011
Emergent BioSolutions to Present at Wedbush 2011 Life Sciences Conference
...
Read More
August 4, 2011
Emergent BioSolutions Reports Financial Results for Second Quarter and First Six Months of 2011
...
Read More
July 11, 2011
Emergent BioSolutions to Release Second Quarter 2011 Financial Results and Conduct a Conference Call on August 4, 2011
...
Read More
June 23, 2011
Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax
...
Read More
June 13, 2011
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Appointed to U.S. Chamber of Commerce Board of Directors
...
Read More
June 9, 2011
Emergent BioSolutions’ Investigational Anthrax Vaccine, NuThrax, Granted Fast Track Designation
...
Read More
June 6, 2011
Emergent BioSolutions Acquires Late-Stage Monoclonal Antibody Cancer Therapy from TenX BioPharma
...
Read More
1
2
…
41
42
43
…
58
59
